Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nitesh Mohan

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Nature Communications|August 2, 2020
Symmetric neural progenitor divisions require chromatin-mediated homologous recombination DNA repair by Ino80Jason M Keil, Daniel Z Doyle, Adel Qalieh, et al.
American Journal of Ophthalmology|June 2, 2026
Immune Checkpoint Inhibitor-Associated Uveitis: Insights from Comparative Analyses Across Malignancies and Drug ClassesVictor Bellanda, Matthew J Schulgit, Khaled A Hassan, et al.
Ophthalmology. Retina|September 6, 2023
Short-Term Outcomes of Faricimab in Patients with Neovascular Age-Related Macular Degeneration on Prior Anti-VEGF TherapyAndrei Szigiato, Nitesh Mohan, Katherine E Talcott, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|April 21, 2025
Early Outcomes of Faricimab Treatment for Diabetic Macular Edema in Patients Previously Treated With Anti-VEGF TherapyNitesh Mohan, Andrei Szigiato, Katherine E Talcott, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|March 17, 2026
Long-term Outcomes of Faricimab in Previously Treated Neovascular Age-related Macular DegenerationNitesh Mohan, Matthew J Schulgit, Victor Bellanda, et al.
Ophthalmology. Retina|September 11, 2025
Screening for Retinal Ischemic Perivascular Lesions in Patients Undergoing Cardiovascular Assessment: A Cross-Sectional StudyVictor Bellanda, Adrienne Delaney, Matthew J Schulgit, et al.
Journal of Vitreoretinal Diseases|October 7, 2025
Real-World Functional and Anatomic Outcomes With Aflibercept 8.0 mg in Patients With Diabetic Macular EdemaGabriel Castilho S Barbosa, Suraj Bala, Nitesh Mohan, et al.
Ophthalmology. Retina|February 9, 2025
Initial Functional and Anatomical Outcomes of High-dose Aflibercept 8 mg in Exudative Neovascular Age-related Macular DegenerationSuraj Bala, Gabriel C S Barbosa, Nitesh Mohan, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Nature Communications|August 2, 2020
Symmetric neural progenitor divisions require chromatin-mediated homologous recombination DNA repair by Ino80Jason M Keil, Daniel Z Doyle, Adel Qalieh, et al.
American Journal of Ophthalmology|June 2, 2026
Immune Checkpoint Inhibitor-Associated Uveitis: Insights from Comparative Analyses Across Malignancies and Drug ClassesVictor Bellanda, Matthew J Schulgit, Khaled A Hassan, et al.
Ophthalmology. Retina|September 6, 2023
Short-Term Outcomes of Faricimab in Patients with Neovascular Age-Related Macular Degeneration on Prior Anti-VEGF TherapyAndrei Szigiato, Nitesh Mohan, Katherine E Talcott, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|April 21, 2025
Early Outcomes of Faricimab Treatment for Diabetic Macular Edema in Patients Previously Treated With Anti-VEGF TherapyNitesh Mohan, Andrei Szigiato, Katherine E Talcott, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|March 17, 2026
Long-term Outcomes of Faricimab in Previously Treated Neovascular Age-related Macular DegenerationNitesh Mohan, Matthew J Schulgit, Victor Bellanda, et al.
Ophthalmology. Retina|September 11, 2025
Screening for Retinal Ischemic Perivascular Lesions in Patients Undergoing Cardiovascular Assessment: A Cross-Sectional StudyVictor Bellanda, Adrienne Delaney, Matthew J Schulgit, et al.
Journal of Vitreoretinal Diseases|October 7, 2025
Real-World Functional and Anatomic Outcomes With Aflibercept 8.0 mg in Patients With Diabetic Macular EdemaGabriel Castilho S Barbosa, Suraj Bala, Nitesh Mohan, et al.
Ophthalmology. Retina|February 9, 2025
Initial Functional and Anatomical Outcomes of High-dose Aflibercept 8 mg in Exudative Neovascular Age-related Macular DegenerationSuraj Bala, Gabriel C S Barbosa, Nitesh Mohan, et al.
Pageof 3